Yinhua Miyanling Tablets

This product can significantly inhibit the infection of mice caused by 6 strains of Escherichia coli, Proteus, and Staphylococcus aureus, and reduce the 48-hour mortality rate of mice; in vitro drug sensitivity experiments have confirmed that this product has a significant inhibitory effect on Escherichia coli, Proteus, and Pseudomonas aeruginosa. This product can reduce the number of white blood cells (WBC) and bacteria in the urine of rats with urinary tract infection, and at the same time increase the urine volume for 10 hours. Animal experiments show that this product also has anti-inflammatory and increases the phagocytic ability of macrophages.

Honeysuckle, Scutellaria barbata, Polygonum multiflorum, Dianthus superbus, Pyrola, Caulis Akebia, Plantago, Lophatherum gracile, Viburnum villosum, and Juncus wicker.

This product is a film-coated tablet, which is dark brown after removing the film coating; it tastes slightly bitter and astringent.

Oral administration. 4 tablets at a time, 4 times a day. Two weeks is a course of treatment. Can be taken for three courses in a row, or follow the doctor's advice.

Not yet clear.

Not yet clear.

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Sealed and moisture-proof (store at 10-30℃).

Tablet core weight 0.25g, each tablet weight 0.5g (film coating)

24 months.

Jilin Huakang Pharmaceutical Co., Ltd.

• Founded in:

  1998-03-30

• Address:

  No. 10 Huakang Street, Dunhua City, Jilin Province

• Tax NO.:

  91222403702400287H

• Registered Funds:

  109.8 million yuan

• Website:

  Log in to view

• Email:

  Log in to view